Suchergebnisse - "Ou, Yijing"

PubPharm (9)

1

H2S-driven chemotherapy and mild photothermal therapy induced mitochondrial reprogramming to promote cuproptosis

enthalten in: Journal of nanobiotechnology | 2024

von Qiao, L. | Ou, Y. | Li, L. | +12

2

$ H_{2} $S-driven chemotherapy and mild photothermal therapy induced mitochondrial reprogramming to promote cuproptosis

enthalten in: Journal of nanobiotechnology | 2024

von Qiao, L. | Ou, Y. | Li, L. | +12

3

H2S-driven Chemotherapy and Mild Photothermal Therapy Induced Mitochondrial Reprogramming to Promote Cuproptosis

enthalten in: ResearchSquare.com | 2024

von Qiao, L. | Ou, Y. | Li, L. | +12

4

Faecalibacterium prausnitzii Improves Lipid Metabolism Disorder and Insulin Resistance in Type 2 Diabetic Mice

enthalten in: British journal of biomedical science | 2023

von Xuan, W. | Ou, Y. | Chen, W. | +8

5

Oxfendazole Induces Apoptosis in Ovarian Cancer Cells by Activating JNK/MAPK Pathway and Inducing Reactive Oxygen Species Generation

enthalten in: Biological & pharmaceutical bulletin | 2023

von Chen, Y. | Wen, C. | Zhong, S. | +11

6

Application of oxfendazole as anti-ovarian cancer drug

enthalten in: Europäisches Patentamt | 2021

von WEN CHUANGYU | LI ZHONGJUN | WU SHUYI | +6

7

Application of adapalene as anti-ovarian cancer drug

enthalten in: Europäisches Patentamt | 2021

von WEN CHUANGYU | LI ZHONGJUN | CHEN YANYA | +6

8

Control method and system for predicting curative effect of external hip position inversion and storage medium

enthalten in: Europäisches Patentamt | 2021

von LI ZHONGJUN | ZENG DAIDI | WU WANHUA | +7

9

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer

enthalten in: OncoTargets and therapy | 2020

von Li, Z. | Huang, L. | Wei, L. | +5

1
[1]